Migraine Prevention

MINNEAPOLIS, Minnesota, Aug. 31, 2026 The American Academy of Neurology (AAN) and the American Headache Society (AHS) have issued...

RALEIGH, N.C. – August 27, 2026 Slate Medicines Inc. announced that the first participant has been dosed in its...

PALO ALTO, Calif., & NEW YORK, July 30, 2026 Evommune announced that the first patient has been dosed in...

SEATTLE, June 17, 2026 Vedana Therapeutics has officially emerged from stealth with $46 million in Series A financing to...

VALBY, Denmark, June 4, 2026 H. Lundbeck A/S has announced encouraging results from its Phase IIb PROCEED clinical trial...

SURESNES, France, June 1, 2026 Servier has announced a landmark agreement to acquire Edgewise Therapeutics’ muscular dystrophy business in...

NORTH CHICAGO, Ill., June 2, 2026 AbbVie has announced that the European Commission (EC) has approved AQUIPTA® (atogepant) for...

MUMBAI, India & NAPLES, Fla., Feb. 4, 2026 — Global pharmaceutical company Lupin Limited announced the U.S. launch of...